Compare Stocks: HSTC, LHSIF, EOLS, and AVIR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVIR Atea Pharmaceuticals	$4.75 +1.1%	$4.61	$2.78 ▼ $6.45	$376.13M	0.3	380,121 shs	258,842 shs
EOLS Evolus	$6.18 +1.0%	$6.46	$3.86 ▼ $7.95	$403.03M	1.35	735,845 shs	1.16 million shs
HSTC HST Global	$0.70	$0.70	$0.00 ▼ $1.05	$99M	-352.99	27 shs	N/A
LHSIF Liberty Health Sciences	$1.14 -2.2%	$1.14	$0.23 ▼ $1.23	$392.01M	1.7	1.67 million shs	671,400 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVIR Atea Pharmaceuticals	+1.95%	+4.21%	-5.62%	-16.81%	+33.14%
EOLS Evolus	+1.16%	-1.61%	-11.30%	-3.16%	-32.82%
HSTC HST Global	0.00%	0.00%	+1.45%	+12.00%	+174,900.00%
LHSIF Liberty Health Sciences	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVIR Atea Pharmaceuticals	$4.75 +1.1%	$4.61	$2.78 ▼ $6.45	$376.13M	0.3	380,121 shs	258,842 shs
EOLS Evolus	$6.18 +1.0%	$6.46	$3.86 ▼ $7.95	$403.03M	1.35	735,845 shs	1.16 million shs
HSTC HST Global	$0.70	$0.70	$0.00 ▼ $1.05	$99M	-352.99	27 shs	N/A
LHSIF Liberty Health Sciences	$1.14 -2.2%	$1.14	$0.23 ▼ $1.23	$392.01M	1.7	1.67 million shs	671,400 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVIR Atea Pharmaceuticals	+1.95%	+4.21%	-5.62%	-16.81%	+33.14%
EOLS Evolus	+1.16%	-1.61%	-11.30%	-3.16%	-32.82%
HSTC HST Global	0.00%	0.00%	+1.45%	+12.00%	+174,900.00%
LHSIF Liberty Health Sciences	0.00%	0.00%	0.00%	0.00%	0.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVIR Atea Pharmaceuticals	2.50	Moderate Buy	N/A	N/A
EOLS Evolus	2.50	Moderate Buy	$16.00	158.90% Upside
HSTC HST Global	0.00	N/A	N/A	N/A
LHSIF Liberty Health Sciences	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest HSTC, LHSIF, EOLS, and AVIR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2026	AVIR Atea Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/17/2026	EOLS Evolus	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$13.00
6/15/2026	EOLS Evolus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/29/2026	EOLS Evolus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
5/13/2026	EOLS Evolus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)

(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVIR Atea Pharmaceuticals	N/A	N/A	N/A	N/A	$3.53 per share	N/A
EOLS Evolus	$297.18M	1.37	N/A	N/A	($0.36) per share	-17.17
HSTC HST Global	$520K	190.39	N/A	N/A	$0.18 per share	3.89
LHSIF Liberty Health Sciences	$37.77M	10.38	$0.04 per share	26.78	$0.31 per share	3.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVIR Atea Pharmaceuticals	-$158.35M	-$2.11	N/A	N/A	N/A	N/A	-57.01%	-51.49%	8/6/2026 (Estimated)
EOLS Evolus	-$51.64M	-$0.67	N/A	103.00	N/A	-14.39%	N/A	-19.03%	8/5/2026 (Confirmed)
HSTC HST Global	-$860K	N/A	N/A	N/A	N/A	-61.47%	-3.65%	-3.39%	N/A
LHSIF Liberty Health Sciences	$16.80M	N/A	38.17	N/A	N/A	19.34%	9.51%	6.78%	N/A

Latest HSTC, LHSIF, EOLS, and AVIR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	AVIR Atea Pharmaceuticals	-$0.56	N/A	N/A	N/A	$33.03 million	N/A
8/5/2026	Q2 2026	EOLS Evolus	-$0.0429	-$0.12	-$0.0771	-$0.12	$81.55 million	$84.08 million
5/12/2026	Q1 2026	AVIR Atea Pharmaceuticals	-$0.60	-$0.57	+$0.03	-$0.57	$22.42 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVIR Atea Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
EOLS Evolus	N/A	N/A	N/A	N/A	N/A
HSTC HST Global	N/A	N/A	N/A	N/A	N/A
LHSIF Liberty Health Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVIR Atea Pharmaceuticals	N/A	7.89	7.89
EOLS Evolus	N/A	2.04	1.68
HSTC HST Global	N/A	0.66	0.29
LHSIF Liberty Health Sciences	N/A	2.93	0.72

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVIR Atea Pharmaceuticals	86.67%
EOLS Evolus	90.69%
HSTC HST Global	N/A
LHSIF Liberty Health Sciences	N/A

Insider Ownership

Company	Insider Ownership
AVIR Atea Pharmaceuticals	21.60%
EOLS Evolus	5.00%
HSTC HST Global	65.82%
LHSIF Liberty Health Sciences	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVIR Atea Pharmaceuticals	70	80.03 million	62.74 million	Optionable
EOLS Evolus	170	65.86 million	62.56 million	Optionable
HSTC HST Global	1	141.43 million	48.34 million	Not Optionable
LHSIF Liberty Health Sciences	291	342.49 million	N/A	Not Optionable

HSTC, LHSIF, EOLS, and AVIR Headlines

Recent News About These Companies

Kansas City-area nursing home closing after losing Medicaid funding agreement

March 6, 2025 | msn.com

HS Fball: Liberty County picks up on Beach’s homecoming

October 25, 2024 | msn.com

Liberty Hill High School teacher celebrates 50 years of teaching

October 23, 2024 | msn.com

Join us as we explore Liberty, North Carolina, for My Town Monday

October 22, 2024 | yahoo.com

Iowa City Liberty’s Logan Laubenthal talks win over Ankeny in Week 7

October 12, 2024 | sports.yahoo.com

Hitters Spokane launches new location in Liberty Lake with advanced batting cages and golf simulators

September 21, 2024 | khq.comK

Liberty High School football team ready for final RCB faceoff

September 13, 2024 | yahoo.com

Ammunition found inside Olentangy Liberty High School

September 6, 2024 | yahoo.com

Liberty Hill ISD football player talks about the 2024-25 school year getting underway

August 30, 2024 | yahoo.com

Liberty Hill ISD Superintendent Steven Snell talks about growth going into the 2024-25 school year

August 30, 2024 | yahoo.com

Liberty HS students gain hands-on experience through internships

August 22, 2024 | bluebonnetnews.comB

High school football preview: Liberty Raiders

August 21, 2024 | sports.yahoo.com

Liberty High alum awarded STAR scholarship

August 15, 2024 | thepress.netT

Liberty County Rivalry headlining week one high school football action

August 15, 2024 | msn.com

Liberty Hill Police chief resigns after 7 years of service

August 13, 2024 | msn.com

Liberty Health reaches the end of the road

August 13, 2024 | moneyweb.co.za

Infographic: Here's some Liberty County data on depression and living alone

August 7, 2024 | sfexaminer.comS

Some students, faculty leave Liberty High School early ahead of merger

August 6, 2024 | yahoo.com

Liberty County Health Brief: Here are some habits that can lower your dementia risk. Doctors Explain

August 4, 2024 | djournal.comD

Miller sidelined, Juhász returns as Lynx host Liberty

May 27, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSTC, LHSIF, EOLS, and AVIR Company Descriptions

Atea Pharmaceuticals NASDAQ:AVIR

$4.75 +0.05 (+1.06%)

Closing price 04:00 PM Eastern

Extended Trading

$4.67 -0.08 (-1.68%)

As of 07:34 PM Eastern

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Evolus NASDAQ:EOLS

$6.18 +0.06 (+0.98%)

Closing price 04:00 PM Eastern

Extended Trading

$6.60 +0.42 (+6.78%)

As of 07:52 PM Eastern

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

HST Global OTCMKTS:HSTC

$0.70 0.00 (0.00%)

As of 08/4/2026

HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

Liberty Health Sciences OTCMKTS:LHSIF

$1.14 -0.03 (-2.17%)

As of 02/26/2021

Liberty Health Sciences Inc. engages in the production and distribution of medical cannabis in the United States. The company offers medical cannabis in the State of Florida through the Florida Department of Health, office of medical marijuana use. As of January 21, 2021, it operated 29 dispensaries in Florida. The company is headquartered in Gainesville, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HSTC, LHSIF, EOLS, and AVIR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HSTC, LHSIF, EOLS, and AVIR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HSTC, LHSIF, EOLS, and AVIR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSTC, LHSIF, EOLS, and AVIR Company Descriptions

Atea Pharmaceuticals NASDAQ:AVIR

Evolus NASDAQ:EOLS

HST Global OTCMKTS:HSTC

Liberty Health Sciences OTCMKTS:LHSIF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HSTC, LHSIF, EOLS, and AVIR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HSTC, LHSIF, EOLS, and AVIR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HSTC, LHSIF, EOLS, and AVIR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSTC, LHSIF, EOLS, and AVIR Company Descriptions

Atea Pharmaceuticals NASDAQ:AVIR

Evolus NASDAQ:EOLS

HST Global OTCMKTS:HSTC

Liberty Health Sciences OTCMKTS:LHSIF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools